Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 08, 2018

SELL
$217.88 - $244.43 $154 Million - $173 Million
-706,490 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$231.6 - $253.39 $164 Million - $179 Million
706,490
706,490 $168 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track John Armitage's Portfolio

Track John Armitage Portfolio

Follow John Armitage (Egerton Capital (Uk) LLP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Egerton Capital (Uk) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Egerton Capital (Uk) LLP and John Armitage with notifications on news.